Airborne Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): What We Know.

Autor:	Samet JM; Colorado School of Public Health, Aurora, Colorado, USA., Prather K; Department of Chemistry and Biochemistry, Scripps Institution of Oceanography, University of California, San Diego, San Diego, California, USA., Benjamin G; American Public Health Association, Washington, D.C., USA., Lakdawala S; Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Lowe JM; Department of Environmental, Agricultural and Occupational Health, University of Nebraska Medical Center, Omaha, Nebraska, USA., Reingold A; Division of Epidemiology, School of Public Health, University of California, Berkeley, Berkeley, California, USA., Volckens J; Department of Mechanical Engineering, Colorado State University, Fort Collins, Colorado, USA., Marr LC; Department of Civil and Environmental Engineering, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USA.
Jazyk:	angličtina
Zdroj:	Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Nov 16; Vol. 73 (10), pp. 1924-1926.
DOI:	10.1093/cid/ciab039
Abstrakt:	We examine airborne transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) potential using a source-to-dose framework beginning with generation of virus-containing droplets and aerosols and ending with virus deposition in the respiratory tract of susceptible individuals. By addressing 4 critical questions, we identify both gaps in addressing 4 critical questions with answers having policy implications. (© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu